Development of bio-engineered drugs in active stage

Published: 2002-03-29 06:57:00

Updated: 2002-03-29 06:57:00

Market analysts say that the development of bio-engieered drugs is making the brisk pace in the domestic market, since many potential drugs are expected to be under clinical trials, following the market approval of Chondron, an anti-arthritic treatment.

The Korea Food and Drug Administration (...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK